TY - JOUR AU - Chan, J. C. AU - Malik, V. AU - Jia, W. PY - 2009 DA - 2009// TI - Diabetes in Asia: epidemiology, risk factors, and pathophysiology JO - JAMA VL - 301 UR - https://doi.org/10.1001/jama.2009.726 DO - 10.1001/jama.2009.726 ID - Chan2009 ER - TY - JOUR AU - Haffner, S. M. AU - Lehto, S. AU - Rönnemaa, T. PY - 1998 DA - 1998// TI - Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199807233390404 DO - 10.1056/NEJM199807233390404 ID - Haffner1998 ER - TY - JOUR AU - Stratton, I. M. AU - Adler, A. I. AU - Neil, H. A. PY - 2000 DA - 2000// TI - Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7258.405 DO - 10.1136/bmj.321.7258.405 ID - Stratton2000 ER - TY - JOUR AU - Uusitupa, M. I. AU - Niskanen, L. K. AU - Siitonen, O. PY - 1990 DA - 1990// TI - 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in noninsulin dependent diabetic and non-diabetic subjects JO - Circulation VL - 82 UR - https://doi.org/10.1161/01.CIR.82.1.27 DO - 10.1161/01.CIR.82.1.27 ID - Uusitupa1990 ER - TY - JOUR AU - Lehto, S. AU - Rönnemaa, T. AU - Haffner, S. M. PY - 1997 DA - 1997// TI - Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM JO - Diabetes VL - 46 UR - https://doi.org/10.2337/diab.46.8.1354 DO - 10.2337/diab.46.8.1354 ID - Lehto1997 ER - TY - JOUR AU - Wahl, P. AU - Hasslacher, C. h. AU - Lang, P. D. PY - 1978 DA - 1978// TI - Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia JO - Dtsch med Wochenschr VL - 103 UR - https://doi.org/10.1055/s-0028-1129237 DO - 10.1055/s-0028-1129237 ID - Wahl1978 ER - TY - JOUR AU - Bruneder, H. AU - Klein, H. J. PY - 1981 DA - 1981// TI - Treatment of hyperlipoproteinaemia in diabetic patients JO - Dtsch Med Wochenschr VL - 106 UR - https://doi.org/10.1055/s-2008-1070572 DO - 10.1055/s-2008-1070572 ID - Bruneder1981 ER - TY - JOUR AU - Tenenbaum, A. AU - Fisman, E. Z. AU - Motro, M. PY - 2008 DA - 2008// TI - Optimal management of combined dyslipidemia: what have we behind statins monotherapy? JO - Adv Cardiol VL - 45 UR - https://doi.org/10.1159/000115192 DO - 10.1159/000115192 ID - Tenenbaum2008 ER - TY - JOUR AU - Krey, G. AU - Braissant, O. AU - L'Horset, F. PY - 1997 DA - 1997// TI - Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay JO - Mol Endocrinol VL - 11 UR - https://doi.org/10.1210/mend.11.6.0007 DO - 10.1210/mend.11.6.0007 ID - Krey1997 ER - TY - JOUR AU - Moya-Camarena, S. Y. AU - Van den Heuvel, J. P. AU - Belury, M. A. PY - 1999 DA - 1999// TI - Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats JO - Biochim Biophys Acta VL - 1436 UR - https://doi.org/10.1016/S0005-2760(98)00121-0 DO - 10.1016/S0005-2760(98)00121-0 ID - Moya-Camarena1999 ER - TY - JOUR AU - Peters, J. M. AU - Aoyama, T. AU - Burns, A. M. PY - 2003 DA - 2003// TI - Bezafibrate is a dual ligand for PPAR alpha and PPAR beta: studies using null mice JO - Biochim Biophys Acta VL - 1632 UR - https://doi.org/10.1016/S1388-1981(03)00065-9 DO - 10.1016/S1388-1981(03)00065-9 ID - Peters2003 ER - TY - JOUR AU - Tenenbaum, A. AU - Motro, M. AU - Fisman, E. AU - Review, Z. PY - 2005 DA - 2005// TI - Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons JO - Cardiovasc Diabetol VL - 4 UR - https://doi.org/10.1186/1475-2840-4-14 DO - 10.1186/1475-2840-4-14 ID - Tenenbaum2005 ER - TY - JOUR AU - Willson, T. M. AU - Brown, P. J. AU - Sternbach, D. D. AU - Henke, B. R. PY - 2000 DA - 2000// TI - The PPARs: from orphan receptors to drug discovery JO - J Med Chem VL - 43 UR - https://doi.org/10.1021/jm990554g DO - 10.1021/jm990554g ID - Willson2000 ER - TY - JOUR AU - Jones, I. R. AU - Swai, A. AU - Taylor, R. PY - 1990 DA - 1990// TI - Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM JO - Diabetes Care VL - 13 UR - https://doi.org/10.2337/diacare.13.8.855 DO - 10.2337/diacare.13.8.855 ID - Jones1990 ER - TY - JOUR AU - Taniguchi, A. AU - Fukudhima, M. AU - Sakai, M. PY - 2001 DA - 2001// TI - Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients JO - Metabolism VL - 50 UR - https://doi.org/10.1053/meta.2001.21028 DO - 10.1053/meta.2001.21028 ID - Taniguchi2001 ER - TY - JOUR AU - Ogawa, S. AU - Takeuchi, K. AU - Sugimura, K. PY - 2000 DA - 2000// TI - Bezafibrate reduces blood glucose in type 2 diabetes mellitus JO - Metabolism VL - 49 UR - https://doi.org/10.1016/S0026-0495(00)90176-8 DO - 10.1016/S0026-0495(00)90176-8 ID - Ogawa2000 ER - TY - JOUR AU - Elkeles, R. PY - 2011 DA - 2011// TI - Fibrates: old drugs with a new role in type 2 diabetes prevention? JO - Br J Diabetes Vasc Dis VL - 11 UR - https://doi.org/10.1177/1474651410397245 DO - 10.1177/1474651410397245 ID - Elkeles2011 ER - TY - JOUR AU - Friedewald, W. T. AU - Levy, R. AU - Fredrickson, D. S. PY - 1972 DA - 1972// TI - Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge JO - Clin Chem VL - 18 ID - Friedewald1972 ER - TY - JOUR PY - 2010 DA - 2010// TI - Report of the Committee on the classification and diagnostic criteria of diabetes mellitus JO - J Jpn Diabetes Soc VL - 53 ID - ref19 ER - TY - JOUR AU - Hokanson, J. E. AU - Austin, M. A. PY - 1996 DA - 1996// TI - Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies JO - J Cardiovasc Risk VL - 3 UR - https://doi.org/10.1097/00043798-199604000-00014 DO - 10.1097/00043798-199604000-00014 ID - Hokanson1996 ER - TY - JOUR AU - Khan, H. A. AU - Sobki, S. H. AU - Khan, S. A. PY - 2007 DA - 2007// TI - Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia JO - Clin Exp Med VL - 7 UR - https://doi.org/10.1007/s10238-007-0121-3 DO - 10.1007/s10238-007-0121-3 ID - Khan2007 ER - TY - JOUR AU - Zhang, L. AU - Qiao, Q. AU - Tuomilehto, J. PY - 2009 DA - 2009// TI - Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study JO - Diabetes Metab Res Rev VL - 25 UR - https://doi.org/10.1002/dmrr.994 DO - 10.1002/dmrr.994 ID - Zhang2009 ER - TY - JOUR AU - Baigent, C. AU - Keech, A. AU - Kearney, P. M. PY - 2005 DA - 2005// TI - Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67394-1 DO - 10.1016/S0140-6736(05)67394-1 ID - Baigent2005 ER - TY - JOUR AU - Mills, E. J. AU - Rachlis, B. AU - Wu, P. AU - Devereaux, P. J. PY - 2008 DA - 2008// TI - Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients JO - J Am Coll Cardiol VL - 52 UR - https://doi.org/10.1016/j.jacc.2008.08.039 DO - 10.1016/j.jacc.2008.08.039 ID - Mills2008 ER - TY - JOUR AU - Brugts, J. J. AU - Yetgin, T. AU - Hoeks, S. E. PY - 2009 DA - 2009// TI - The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials JO - BMJ VL - 338 UR - https://doi.org/10.1136/bmj.b2376 DO - 10.1136/bmj.b2376 ID - Brugts2009 ER - TY - JOUR AU - Baigent, C. AU - Blackwell, L. AU - Emberson, J. PY - 2010 DA - 2010// TI - Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61350-5 DO - 10.1016/S0140-6736(10)61350-5 ID - Baigent2010 ER - TY - JOUR AU - Mazza, F. AU - Stefanutti, C. AU - Di Giacomo, S. PY - 2008 DA - 2008// TI - Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia JO - Am J Cardiovasc Drugs VL - 8 UR - https://doi.org/10.2165/00129784-200808040-00006 DO - 10.2165/00129784-200808040-00006 ID - Mazza2008 ER - TY - JOUR AU - Saito, Y. AU - Yamada, N. AU - Shirai, K. PY - 2007 DA - 2007// TI - Effect of rosuvastatin 5-20 mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia JO - Atherosclerosis VL - 194 UR - https://doi.org/10.1016/j.atherosclerosis.2006.11.028 DO - 10.1016/j.atherosclerosis.2006.11.028 ID - Saito2007 ER - TY - JOUR AU - Jun, M. AU - Foote, C. AU - Lv, J. PY - 2010 DA - 2010// TI - Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(10)60656-3 DO - 10.1016/S0140-6736(10)60656-3 ID - Jun2010 ER - TY - JOUR PY - 2010 DA - 2010// TI - Effects of combination lipid therapy in type 2 diabetes mellitus JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa1001282 DO - 10.1056/NEJMoa1001282 ID - ref30 ER - TY - JOUR AU - Tenenbaum, A. AU - Fisman, E. Z. PY - 2010 DA - 2010// TI - "If it ain't broke, don't fix it": a commentary on the positive- negative results of the ACCORD Lipid study JO - Cardiovasc Diabetol VL - 9 UR - https://doi.org/10.1186/1475-2840-9-24 DO - 10.1186/1475-2840-9-24 ID - Tenenbaum2010 ER - TY - JOUR PY - 2000 DA - 2000// TI - Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study JO - Circulation VL - 102 UR - https://doi.org/10.1161/01.CIR.102.1.21 DO - 10.1161/01.CIR.102.1.21 ID - ref32 ER - TY - JOUR PY - 2010 DA - 2010// TI - Effects of combination lipid therapy in type 2 diabetes mellitus JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMicm0810550 DO - 10.1056/NEJMicm0810550 ID - ref33 ER - TY - JOUR PY - 2005 DA - 2005// TI - Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67667-2 DO - 10.1016/S0140-6736(05)67667-2 ID - ref34 ER - TY - JOUR AU - Sattar, N. AU - Preiss, D. AU - Murray, H. M. PY - 2010 DA - 2010// TI - Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61965-6 DO - 10.1016/S0140-6736(09)61965-6 ID - Sattar2010 ER - TY - JOUR AU - Rajapathak, S. N. AU - Kumbhani, D. J. AU - Crandall, J. PY - 2009 DA - 2009// TI - Statin therapy and risk of developing type 2 diabetes: a meta-analysis JO - Diabetes Care VL - 32 UR - https://doi.org/10.2337/dc09-0738 DO - 10.2337/dc09-0738 ID - Rajapathak2009 ER - TY - JOUR AU - Elkeles, R. S. AU - Diamond, J. R. AU - Poulter, C. PY - 1998 DA - 1998// TI - Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study JO - Diabetes Care VL - 21 UR - https://doi.org/10.2337/diacare.21.4.641 DO - 10.2337/diacare.21.4.641 ID - Elkeles1998 ER - TY - JOUR AU - Tenenbaum, A. AU - Motro, M. AU - Fisman, E. Z. PY - 2004 DA - 2004// TI - Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease JO - Circulation VL - 109 UR - https://doi.org/10.1161/01.CIR.0000126824.12785.B6 DO - 10.1161/01.CIR.0000126824.12785.B6 ID - Tenenbaum2004 ER - TY - JOUR AU - Bays, H. AU - Mandarino, L. AU - DeFronzo, R. A. PY - 2004 DA - 2004// TI - Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2003-030723 DO - 10.1210/jc.2003-030723 ID - Bays2004 ER - TY - JOUR AU - Tremblay-Mercier, J. AU - Tessier, D. AU - Plourde, M. PY - 2010 DA - 2010// TI - Bezafibrate mildly stimulates ketogenesis and fatty acid metabolism in hypertriglyceridemic subjects JO - J Pharmacol Exp Ther VL - 334 UR - https://doi.org/10.1124/jpet.110.166504 DO - 10.1124/jpet.110.166504 ID - Tremblay-Mercier2010 ER - TY - JOUR AU - Cabrero, A. AU - Alegret, M. AU - Sánchez, R. M. PY - 2001 DA - 2001// TI - Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes JO - Diabetes VL - 50 UR - https://doi.org/10.2337/diabetes.50.8.1883 DO - 10.2337/diabetes.50.8.1883 ID - Cabrero2001 ER - TY - JOUR AU - Nagasawa, T. AU - Inada, Y. AU - Nakano, S. PY - 2006 DA - 2006// TI - Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPAR delta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet JO - Eur J Pharmacol VL - 536 UR - https://doi.org/10.1016/j.ejphar.2006.02.028 DO - 10.1016/j.ejphar.2006.02.028 ID - Nagasawa2006 ER - TY - JOUR AU - Van der Zijl, N. J. AU - Goossens, G. H. AU - Moors, C. C. PY - 2011 DA - 2011// TI - Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism JO - J Clin Endocrinol Metab VL - 96 UR - https://doi.org/10.1210/jc.2010-1722 DO - 10.1210/jc.2010-1722 ID - Van der Zijl2011 ER - TY - JOUR AU - Fernandes-Santos, C. AU - Evangelista Carneiro, R. AU - de Souza Mendonca, L. PY - 2009 DA - 2009// TI - Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet JO - Pancreas VL - 38 UR - https://doi.org/10.1097/MPA.0b013e3181987d9d DO - 10.1097/MPA.0b013e3181987d9d ID - Fernandes-Santos2009 ER - TY - JOUR AU - Betteridge, D. J. AU - O'Bryan-Tear, C. G. PY - 1996 DA - 1996// TI - Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemia JO - Postgrad Med J VL - 72 UR - https://doi.org/10.1136/pgmj.72.854.739 DO - 10.1136/pgmj.72.854.739 ID - Betteridge1996 ER - TY - JOUR AU - Beggs, P. W. AU - Clark, D. W. AU - Williams, S. M. PY - 1999 DA - 1999// TI - A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP) JO - Br J Clin Pharmacol VL - 47 UR - https://doi.org/10.1046/j.1365-2125.1999.00846.x DO - 10.1046/j.1365-2125.1999.00846.x ID - Beggs1999 ER - TY - JOUR AU - Nathan, D. M. AU - Buse, J. B. AU - Davidson, M. B. PY - 2006 DA - 2006// TI - Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes JO - Diabetes Care VL - 29 UR - https://doi.org/10.2337/dc06-9912 DO - 10.2337/dc06-9912 ID - Nathan2006 ER - TY - JOUR AU - Sone, H. AU - Ito, H. AU - Ohashi, Y. PY - 2003 DA - 2003// TI - Obesity and type 2 diabetes in Japanese patients JO - Lancet VL - 361 UR - https://doi.org/10.1016/S0140-6736(03)12151-4 DO - 10.1016/S0140-6736(03)12151-4 ID - Sone2003 ER - TY - JOUR AU - John, W. G. AU - Mosca, A. AU - Weykamp, C. PY - 2007 DA - 2007// TI - HbA1c standardisation: history, science and politics JO - Clin Biochem Rev VL - 28 ID - John2007 ER - TY - JOUR AU - Nihei, T. AU - Saitou, T. AU - Yokoyama, T. PY - 2011 DA - 2011// TI - Evaluation for commutability of hemoglobin A1c measurement by IFCC calibration JO - JJCLA VL - 36 ID - Nihei2011 ER -